These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19643519)

  • 1. Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
    Delgado J; Briones J; Sierra J
    Blood Rev; 2009 Sep; 23(5):217-24. PubMed ID: 19643519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
    Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavopiridol in chronic lymphocytic leukemia: a concise review.
    Christian BA; Grever MR; Byrd JC; Lin TS
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S179-85. PubMed ID: 19778838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic lymphocytic leukemia.
    Faderl SJ; Keating MJ
    Curr Hematol Rep; 2005 Jan; 4(1):31-8. PubMed ID: 15610657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapies for chronic lymphocytic leukemia in the 21st century.
    Byrd JC; Waselenko JK; Keating M; Rai K; Grever MR
    Semin Oncol; 2000 Oct; 27(5):587-97. PubMed ID: 11049025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in chronic lymphocytic leukemia.
    Ferrajoli A; Faderl S; Keating MJ
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapy for chronic lymphocytic leukaemia.
    Auer RL; Gribben J; Cotter FE
    Br J Haematol; 2007 Dec; 139(5):635-44. PubMed ID: 17961187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
    Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E
    Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
    Klepfish A; Rachmilewitz EA; Kotsianidis I; Patchenko P; Schattner A
    QJM; 2008 Sep; 101(9):737-40. PubMed ID: 18650226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
    Abbott BL
    Oncologist; 2006 Jan; 11(1):21-30. PubMed ID: 16401710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial therapy for patients with chronic lymphocytic leukemia.
    Wierda WG; O'Brien SM
    Semin Oncol; 2006 Apr; 33(2):202-9. PubMed ID: 16616067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia.
    Grever MR; Lucas DM; Johnson AJ; Byrd JC
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):545-56. PubMed ID: 17707839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the front-line management of chronic lymphocytic leukemia.
    Nabhan C; Shanafelt TD; Kay NE
    Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
    Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
    Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the treatment of chronic lymphocytic leukaemia].
    Mozas P; Delgado J
    Med Clin (Barc); 2016 Nov; 147(10):447-454. PubMed ID: 27431885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
    Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
    Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia: a niche for flavopiridol?
    Brown JR
    Clin Cancer Res; 2005 Jun; 11(11):3971-3. PubMed ID: 15930331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.